Development and validation of a prognostic model for 90‐day survival in patients with alcohol‐associated cirrhosis and acute decompensation

Ähnliche Einträge

• Rifaximin treatment shapes a unique metagenome‐metabolism network in patients with decompensated cirrhosis
  von: Mei‐Tong Nie, et al.
  Veröffentlicht: (2024)
• Total bile acids levels as a stratification tool for screening portopulmonary hypertension in patients with decompensated cirrhosis
  von: Kazuaki Tajima, et al.
  Veröffentlicht: (2024)
• Integrated policy of medical expense subsidies and clinical registry for patients with liver cancer and decompensated cirrhosis in Japan
  von: Yasue Takeuchi, et al.
  Veröffentlicht: (2024)
• Prognostic significance of skeletal muscle mass in patients with alcohol‐related cirrhosis
  von: Akihiko Shibamoto, et al.
  Veröffentlicht: (2025)
• Serum pro‐inflammatory cytokine interleukin‐6 level is predictive of further decompensation and mortality in liver cirrhosis
  von: Yuji Ikeda, et al.
  Veröffentlicht: (2025)